Laquinimod (LAQ) is an effective immunomodulator, which is currently under development in phase III trials for the treatment of multiple sclerosis as an oral therapy.
Molecular Weight:
356.8
Purity:
98.84%
CAS Number:
[248281-84-7]
Formula:
C19H17ClN2O3
Target:
NF-kappaB|||Apoptosis
T6561
* VAT and and shipping costs not included. Errors and price changes excepted